{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:27:04Z","timestamp":1793345224606,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.arr.2026.103186","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:13:10Z","timestamp":1779721990000},"page":"103186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting tau-mitochondrial crosstalk in Alzheimer\u2019s disease with an Integrative multi-omics and artificial intelligence driven tools for the development of disease-modifying therapeutics"],"prefix":"10.1016","volume":"119","author":[{"given":"Shanmugam","family":"Bhasha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Chintada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manne","family":"Munikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeesh","family":"Maddineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuvardhan","family":"Nagulavancha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thejomayi","family":"Malempati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Swapna","family":"Gadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran Kumar Reddy","family":"Sankepally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeepkiran Jangampalli","family":"Adi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.arr.2026.103186_bib1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3390\/ph18111731","article-title":"Targeting Amyloid-\u03b2 Proteins as Potential Alzheimer\u2019s Disease Therapeutics: Anti-Amyloid Drug Discovery, Emerging Therapeutics, Clinical Trials and Implications for Public Health","volume":"18","author":"Abduljawad","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.arr.2026.103186_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-032-03370-3_10","article-title":"Macromolecular Crowding in Cytoplasm and Cellular Organelles","author":"Adilovi\u0107","year":"2025","journal-title":"Macro) Mol. Crowding Life Pottage"},{"issue":"20","key":"10.1016\/j.arr.2026.103186_bib3","doi-asserted-by":"crossref","first-page":"10003","DOI":"10.3390\/ijms262010003","article-title":"Network-Medicine-Guided Drug Repurposing for Alzheimer\u2019s Disease: A Multi-Dimensional Systems Pharmacology Approach","volume":"26","author":"Akg\u00fcller","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103186_bib4","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and amyotrophic lateral sclerosis-an updated review","volume":"71","author":"Alqahtani","year":"2023","journal-title":"Mitochondrion"},{"key":"10.1016\/j.arr.2026.103186_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.nbd.2013.10.018","article-title":"AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons","volume":"62","author":"Amadoro","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14656566.2024.2438317","article-title":"Recent advances in Alzheimer\u2019s disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein","volume":"26","author":"Antony","year":"2025","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.arr.2026.103186_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","article-title":"Tau and tauopathies","volume":"126","author":"Arendt","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.arr.2026.103186_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.conb.2017.03.007","article-title":"Glucose metabolism in nerve terminals","volume":"45","author":"Ashrafi","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.arr.2026.103186_bib9","first-page":"1","article-title":"The metabolic engine of cognition: microglia\u2013neuron interactions in health, ageing and disease","author":"Asimakidou","year":"2025","journal-title":"Nat. Metab."},{"issue":"21","key":"10.1016\/j.arr.2026.103186_bib10","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1242\/jcs.113662","article-title":"PGC1\u03b1 and mitochondrial metabolism\u2014Emerging concepts and relevance in ageing and neurodegenerative disorders","volume":"125","author":"Austin","year":"2012","journal-title":"J. Cell Sci."},{"issue":"6","key":"10.1016\/j.arr.2026.103186_bib11","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199356","article-title":"Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer\u2019s disease","volume":"16","author":"Bader","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: A network-based approach to human disease","volume":"12","author":"Barab\u00e1si","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"5","key":"10.1016\/j.arr.2026.103186_bib13","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000194","article-title":"The Alzheimer\u2019s Disease Sequencing Project: Study design and sample selection","volume":"3","author":"Beecham","year":"2017","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.arr.2026.103186_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13073-019-0701-3","article-title":"Digital twins to personalize medicine","volume":"12","author":"Bj\u00f6rnsson","year":"2020","journal-title":"Genome Med."},{"issue":"3","key":"10.1016\/j.arr.2026.103186_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"Blennow","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.arr.2026.103186_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: Mechanistic insights","volume":"12","author":"Bov\u00e9","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.arr.2026.103186_bib17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"17","key":"10.1016\/j.arr.2026.103186_bib18","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.3390\/jcm14176047","article-title":"Clinical significance of APOE4 genotyping: potential for personalized therapy and early diagnosis of Alzheimer\u2019s Disease","volume":"14","author":"Bumber","year":"2025","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.arr.2026.103186_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","volume":"23","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41398-025-03367-7","article-title":"Bioenergetic biomarkers as predictive indicators and their relationship with cognitive function in newly diagnosed, drug-na\u00efve patients with bipolar disorder","volume":"15","author":"Cao","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2026.103186_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","article-title":"Mitochondrial dynamics and its involvement in disease","volume":"15","author":"Chan","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.arr.2026.103186_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/S0070-2153(04)59005-1","article-title":"Mitochondrial dynamics in mammals","volume":"59","author":"Chen","year":"2004","journal-title":"Curr. Top. Dev. Biol."},{"issue":"11","key":"10.1016\/j.arr.2026.103186_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70657","article-title":"AMPK\/SIRT1\/PGC-1\u03b1 Signaling Pathway: Molecular Mechanisms and Targeted Strategies From Energy Homeostasis Regulation to Disease Therapy","volume":"31","author":"Chen","year":"2025","journal-title":"CNS Neurosci. & Ther."},{"key":"10.1016\/j.arr.2026.103186_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/bs.apcsb.2024.09.002","article-title":"Tau protein structure and dynamics","volume":"147","author":"Chinnathambi","year":"2025","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib25","article-title":"The role of autophagy in excitotoxicity, synaptic mitochondrial stress and neurodegeneration","volume":"4","author":"Chu","year":"2025","journal-title":"Autophagy Rep."},{"key":"10.1016\/j.arr.2026.103186_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.redox.2018.01.008","article-title":"13 reasons why the brain is susceptible to oxidative stress","volume":"15","author":"Cobley","year":"2018","journal-title":"Redox Biol."},{"issue":"7","key":"10.1016\/j.arr.2026.103186_bib27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.arr.2026.103186_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70318","article-title":"The Neurochemical Landscape of Oligodendrocyte Physiology: From Myelination to Metabolic and Synaptic Modulation","volume":"169","author":"Correale","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2026.103186_bib29","unstructured":"Corsi, A. (2025). Development of molecular tools and cellular models for the characterization of regulatory mechanisms of Tau protein alternative splicing."},{"issue":"3","key":"10.1016\/j.arr.2026.103186_bib30","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899360","article-title":"Disease-associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria","volume":"38","author":"Cummins","year":"2019","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nut.2010.07.021","article-title":"Brain fuel metabolism, aging, and Alzheimer\u2019s disease","volume":"27","author":"Cunnane","year":"2011","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/acschemneuro.5c00323","article-title":"Synuclein and mitochondrial dysfunction: regulating the protein import complex toward PD treatment?","volume":"17","author":"Dash","year":"2026","journal-title":"ACS Chem. Neurosci."},{"issue":"25","key":"10.1016\/j.arr.2026.103186_bib33","doi-asserted-by":"crossref","first-page":"23802","DOI":"10.1074\/jbc.M500356200","article-title":"Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice","volume":"280","author":"David","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.arr.2026.103186_bib34","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nn.3786","article-title":"Alzheimer\u2019s disease: Early alterations in brain DNA methylation","volume":"17","author":"De Jager","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.arr.2026.103186_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer\u2019s disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"issue":"5866","key":"10.1016\/j.arr.2026.103186_bib36","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1126\/science.1152993","article-title":"Differential regulation of dynein and kinesin motor proteins by tau","volume":"319","author":"Dixit","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40122-024-00690-7","article-title":"The global burden of migraine: A 30-Year trend review and future projections by age, sex, country, and region","volume":"14","author":"Dong","year":"2025","journal-title":"Pain. Ther."},{"issue":"2","key":"10.1016\/j.arr.2026.103186_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: Experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.arr.2026.103186_bib39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2013.03.002","article-title":"Why size matters balancing mitochondrial dynamics in Alzheimer\u2019s disease","volume":"36","author":"DuBoff","year":"2013","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.arr.2026.103186_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11011-025-01712-9","article-title":"Impaired Synaptic Plasticity Mechanisms in Alzheimer\u2019s Disease","volume":"40","author":"Ebrahimi","year":"2025","journal-title":"Metab. Brain Dis."},{"issue":"8","key":"10.1016\/j.arr.2026.103186_bib42","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.bbadis.2013.08.013","article-title":"March separate, strike together role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer disease","volume":"1842","author":"Eckert","year":"2014","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"issue":"16","key":"10.1016\/j.arr.2026.103186_bib43","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.3390\/ijms26168072","article-title":"Blueprint of Collapse: Precision Biomarkers, Molecular Cascades, and the Engineered Decline of Fast-Progressing ALS","volume":"26","author":"\u0218erban","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.arr.2026.103186_bib44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41593-018-0332-9","article-title":"Mitophagy inhibits amyloid-\u03b2 and tau pathology and reverses cognitive deficits in models of Alzheimer\u2019s disease","volume":"22","author":"Fang","year":"2019","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2026.103186_bib45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fnins.2018.00342","article-title":"Mitochondrial quality control in neurodegenerative diseases: focus on Parkinson\u2019s disease and Huntington\u2019s disease","volume":"12","author":"Franco-Iborra","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2026.103186_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s43440-025-00819-1","article-title":"Mitochondria as a therapeutic target in neurodegeneration caused by hypoxia and ischemia during the perinatal period","author":"Fra\u0144czak","year":"2026","journal-title":"Pharmacol. Rep."},{"issue":"9","key":"10.1016\/j.arr.2026.103186_bib47","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41588-024-01898-1","article-title":"Disease prediction with multi-omics and biomarkers empowers case\u2013control genetic discoveries in the UK Biobank","volume":"56","author":"Garg","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.arr.2026.103186_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2026.103186_bib49","series-title":"Deaf Mental Health: From Theory to Practice","first-page":"3","article-title":"The Benefits and Challenges of Specialized Mental Health Practice in the Deaf Community","author":"Gile","year":"2026"},{"issue":"12","key":"10.1016\/j.arr.2026.103186_bib50","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","article-title":"A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation","volume":"22","author":"Grubman","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"13","key":"10.1016\/j.arr.2026.103186_bib51","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.arr.2026.103186_bib52","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.240035","article-title":"Beyond amyloid and tau: rethinking Alzheimer\u2019s disease through less explored avenues","volume":"14","author":"Gyimesi","year":"2024","journal-title":"Open Biol."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14368","article-title":"Ketogenic \u03b2-hydroxybutyrate regulates \u03b2-hydroxybutyrylation of TCA cycle-associated enzymes and attenuates disease-associated pathologies in Alzheimer's mice","volume":"24","author":"Han","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.arr.2026.103186_bib54","series-title":"Systems Biology Approaches: Prevention, Diagnosis, and Understanding Mechanisms of Complex Diseases","first-page":"343","article-title":"The important role of systems biology in neuroscience and neurology and its associated diseases","author":"Haripriyaa","year":"2024"},{"key":"10.1016\/j.arr.2026.103186_bib55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13024-025-00872-7","article-title":"A manifesto for Alzheimer\u2019s disease drug discovery in the era of disease-modifying therapies","volume":"20","author":"Hering","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"11","key":"10.1016\/j.arr.2026.103186_bib57","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: The next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"8","key":"10.1016\/j.arr.2026.103186_bib58","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","article-title":"NAD\u207a supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency","volume":"115","author":"Hou","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"14","key":"10.1016\/j.arr.2026.103186_bib59","doi-asserted-by":"crossref","first-page":"17356","DOI":"10.18632\/oncotarget.7861","article-title":"Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin","volume":"7","author":"Hu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.arr.2026.103186_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1736487","article-title":"Mitochondrial dynamics in cisplatin resistance: molecular mechanisms and therapeutic targeting","volume":"15","author":"Huang","year":"2026","journal-title":"Front. Oncol."},{"issue":"8","key":"10.1016\/j.arr.2026.103186_bib61","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jdad3010001","article-title":"The Cerebral Clearance Cascade as a Driver of Alzheimer\u2019s Disease Progression","volume":"3","author":"Izrael","year":"2025","journal-title":"J. Dement. Alzheimer's. Dis."},{"issue":"4","key":"10.1016\/j.arr.2026.103186_bib63","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019S. & Dement."},{"issue":"5\u20137","key":"10.1016\/j.arr.2026.103186_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1515\/hsz-2025-0110","article-title":"Unclogging of the TOM complex under import stress","volume":"406","author":"Jackson","year":"2025","journal-title":"Biol. Chem."},{"key":"10.1016\/j.arr.2026.103186_bib65","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer\u2019s disease brain andcerebrospinal fluid reveals early changes in energy metabolism associated withmicroglia and astrocyte activation","volume":"26","author":"Johnson","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib66","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13024-018-0282-4","article-title":"Deep proteomic network analysis of Alzheimer\u2019s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease","volume":"13","author":"Johnson","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.arr.2026.103186_bib67","doi-asserted-by":"crossref","first-page":"C641","DOI":"10.1152\/ajpcell.00222.2006","article-title":"Mitochondria and neuronal activity","volume":"292","author":"Kann","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"4","key":"10.1016\/j.arr.2026.103186_bib68","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: New insights from clinical trials","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.arr.2026.103186_bib69","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1007\/s12035-024-04469-x","article-title":"Role of mitochondrial dysfunctions in neurodegenerative disorders: advances in mitochondrial biology","volume":"62","author":"Kathiresan","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.arr.2026.103186_bib70","article-title":"Public health challenges and responses to the growing ageing populations","volume":"3","author":"Khan","year":"2024","journal-title":"Public Health Chall."},{"key":"10.1016\/j.arr.2026.103186_bib71","series-title":"Biomarkers of Neurodegenerative Disorders: Current Progress and Future Directions","first-page":"29","article-title":"Fluid Markers of Tau Pathology","author":"Khan","year":"2025"},{"issue":"2","key":"10.1016\/j.arr.2026.103186_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002375","article-title":"Ten years of pathway analysis: Current approaches and outstanding challenges","volume":"8","author":"Khatri","year":"2012","journal-title":"PLoS Comput. Biol."},{"issue":"11","key":"10.1016\/j.arr.2026.103186_bib73","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/s41589-025-01987-0","article-title":"Interactions with tau\u2019s microtubule-binding repeats modulate amyloid-\u03b2 aggregation and toxicity","volume":"21","author":"Kim","year":"2025","journal-title":"Nat. Chem. Biol."},{"issue":"11","key":"10.1016\/j.arr.2026.103186_bib74","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: Methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2026.103186_bib76","article-title":"Protein Kinases in Alzheimer\u2019s Disease: Pioneering Insights into Pathogenesis and Therapeutic Breakthroughs","author":"Lari","year":"2025","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2026.103186_bib77","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.arr.2026.103186_bib78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.arr.2026.103186_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70237","article-title":"Alzheimer's Disease Sequencing Project release 4 whole genome sequencing dataset","volume":"21","author":"Leung","year":"2025","journal-title":"Alzheimer's. & Dement."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib80","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s40001-025-02699-w","article-title":"The role of mitochondrial dysfunction in the pathogenesis of Alzheimer\u2019s disease and future strategies for targeted therapy","volume":"30","author":"Li","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"6","key":"10.1016\/j.arr.2026.103186_bib81","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3920","article-title":"Machine learning applications in genetics and genomics","volume":"16","author":"Libbrecht","year":"2015","journal-title":"Nat. Rev. Genet."},{"issue":"7113","key":"10.1016\/j.arr.2026.103186_bib82","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103186_bib83","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2147\/CIA.S534015","article-title":"Pathological Mechanisms and Molecular Imaging Advances in Alzheimer\u2019s Disease","author":"Liu","year":"2025","journal-title":"Clin. Interv. Aging"},{"issue":"2","key":"10.1016\/j.arr.2026.103186_bib84","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: An update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.arr.2026.103186_bib85","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nn.3782","article-title":"Methylomic profiling implicates cortical deregulation of ANK1","volume":"17","author":"Lunnon","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2026.103186_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109743","article-title":"Down-regulation of the mitochondrial fusion protein Opa1\/Mfn2 promotes cardiomyocyte hypertrophy in Su5416\/hypoxia-induced pulmonary hypertension rats","volume":"747","author":"Luo","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.arr.2026.103186_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-025-02305-7","article-title":"A machine learning\u2013enabled blood transcriptomic signature for digital diagnosis and subtyping of Alzheimer\u2019s disease","author":"Ma","year":"2026","journal-title":"npj Digit. Med."},{"issue":"11","key":"10.1016\/j.arr.2026.103186_bib88","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/hmg\/dds072","article-title":"Abnormal interaction between Drp1 and hyperphosphorylated tau in Alzheimer\u2019s disease neurons","volume":"21","author":"Manczak","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.arr.2026.103186_bib89","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer\u2019s disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103186_bib90","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41593-020-00787-0","article-title":"Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex","volume":"24","author":"Maynard","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"25","key":"10.1016\/j.arr.2026.103186_bib91","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.2174\/138161210793176581","article-title":"Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer\u2019s disease","volume":"16","author":"Medina","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib92","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40001-025-02297-w","article-title":"Bioinformatics insights into mitochondrial and immune gene regulation in Alzheimer's disease","volume":"30","author":"Meng","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.arr.2026.103186_bib93","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2012.12.042","article-title":"RNA-Seq analysis of the parietal cortex in Alzheimer\u2019s disease reveals alternatively spliced isoforms related to lipid metabolism","volume":"536","author":"Mills","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2026.103186_bib94","article-title":"Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of Alzheimer\u2019s Disease","author":"Mishra","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2026.103186_bib95","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1427.007","article-title":"Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer\u2019s disease","volume":"1147","author":"Mosconi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.arr.2026.103186_bib97","series-title":"Handbook of aging, health and public policy: perspectives from Asia","first-page":"99","article-title":"Global population aging, 1950\u20132050","author":"Navaneetham","year":"2025"},{"key":"10.1016\/j.arr.2026.103186_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2025.103398","article-title":"Mapping multipathology via spatial omic integration","volume":"97","author":"Palaganas","year":"2026","journal-title":"Curr. Opin. Biotechnol."},{"issue":"11","key":"10.1016\/j.arr.2026.103186_bib99","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow. & Metab."},{"issue":"11","key":"10.1016\/j.arr.2026.103186_bib100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41580-024-00753-9","article-title":"Cellular and pathological functions of tau","volume":"25","author":"Parra Bravo","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib101","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s12035-025-05634-6","article-title":"Circulating Vesicular Biomarkers in Alzheimer\u2019s Disease: From Mechanistic Insights to Clinical Applications","volume":"63","author":"Patil","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2026.103186_bib102","series-title":"Neuroinflammation and Autophagy in Neurodegeneration: Mechanistic Insights into Cellular Biology and Advanced Multimodal Therapeutics","first-page":"33","article-title":"Glial Cells, Cytokines, and Inflammasomes in Neurodegeneration","author":"Patil","year":"2025"},{"issue":"5","key":"10.1016\/j.arr.2026.103186_bib103","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41401-025-01709-1","article-title":"Protopanaxatriol restores cognitive function in okadaic acid-treated mice via direct inhibition of pathological CDK5 activity","volume":"47","author":"Peng","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.arr.2026.103186_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fninf.2024.1443865","article-title":"The ROSMAP project: aging and neurodegenerative diseases through omic sciences","volume":"18","author":"P\u00e9rez-Gonz\u00e1lez","year":"2024","journal-title":"Front. Neuroinformatics"},{"key":"10.1016\/j.arr.2026.103186_bib105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00401-018-1903-2","article-title":"Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer\u2019s disease","volume":"136","author":"Pickett","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.arr.2026.103186_bib106","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","article-title":"Mitophagy and quality control mechanisms in mitochondrial maintenance","volume":"28","author":"Pickles","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.arr.2026.103186_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112918","article-title":"Are mitophagy enhancers therapeutic targets for Alzheimer's disease?","volume":"149","author":"Pradeepkiran","year":"2022","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.arr.2026.103186_bib108","unstructured":"Prince, M., Wimo, A., Guerchet, M., Ali, G.C., Wu, Y.T., & Prina, M. (2015). World Alzheimer report 2015. Alzheimer\u2019s Disease International."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"28","key":"10.1016\/j.arr.2026.103186_bib110","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1074\/jbc.M808908200","article-title":"Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease","volume":"284","author":"Quintanilla","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103186_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2025.102750","article-title":"Understanding the complex interplay between tau, amyloid and the network in the spatiotemporal progression of Alzheimer\u2019s Disease","author":"Raj","year":"2025","journal-title":"Prog. Neurobiol."},{"issue":"19","key":"10.1016\/j.arr.2026.103186_bib112","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1021\/acschemneuro.5c00356","article-title":"The Aggregation Continuum of \u03b1-Synuclein and Its Relevance to Brain Aging","volume":"16","author":"Rana","year":"2025","journal-title":"ACS Chem. Neurosci."},{"issue":"D1","key":"10.1016\/j.arr.2026.103186_bib113","doi-asserted-by":"crossref","first-page":"D1541","DOI":"10.1093\/nar\/gkaa1011","article-title":"MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations","volume":"49","author":"Rath","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.arr.2026.103186_bib114","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainres.2011.07.052","article-title":"Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease","volume":"1415","author":"Reddy","year":"2011","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.arr.2026.103186_bib115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer\u2019s disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"47","key":"10.1016\/j.arr.2026.103186_bib116","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1073\/pnas.0905529106","article-title":"Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice","volume":"106","author":"Rhein","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.arr.2026.103186_bib117","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm3412","article-title":"Mitochondria as sensors and regulators of calcium signalling","volume":"13","author":"Rizzuto","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.arr.2026.103186_bib118","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2026.103186_bib119","article-title":"Mitochondrial membrane potential and compartmentalized signaling: Calcium, ROS, and beyond","author":"Selim","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.arr.2026.103186_bib120","unstructured":"She, X. (2025). Targeting the Synergistic Interaction of Pathologies in Alzheimer's Disease: Rationale and Prospects for Combination Therapy. arXiv preprint arXiv:2512.10981."},{"issue":"6","key":"10.1016\/j.arr.2026.103186_bib121","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.tcb.2017.01.005","article-title":"The interplay of axonal energy homeostasis and mitochondrial trafficking and anchoring","volume":"27","author":"Sheng","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"2","key":"10.1016\/j.arr.2026.103186_bib122","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrn3156","article-title":"Mitochondrial transport in neurons: Impact on synaptic homeostasis and neurodegeneration","volume":"13","author":"Sheng","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.arr.2026.103186_bib123","series-title":"The Neurodegeneration Revolution","first-page":"117","article-title":"Current pharmacological treatments for neurodegenerative diseases","author":"Shukla","year":"2025"},{"key":"10.1016\/j.arr.2026.103186_bib124","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria-targeted antioxidant MitoQ","volume":"1201","author":"Smith","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.arr.2026.103186_bib125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","article-title":"Tau pathology and neurodegeneration","volume":"12","author":"Spillantini","year":"2013","journal-title":"Lancet Neurol."},{"issue":"5713","key":"10.1016\/j.arr.2026.103186_bib126","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1126\/science.1105681","article-title":"Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s disease","volume":"307","author":"Stokin","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.arr.2026.103186_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.arr.2026.103186_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107807","article-title":"Identification of conserved proteomic networks in dementia","volume":"31","author":"Swarup","year":"2020","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.arr.2026.103186_bib129","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.arr.2026.103186_bib130","first-page":"335","article-title":"Mechanisms of mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"15","author":"Swerdlow","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"S2","key":"10.1016\/j.arr.2026.103186_bib131","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis","volume":"20","author":"Swerdlow","year":"2014","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib132","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: The convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib133","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/0109298665348075241121071614","article-title":"Exploring New Structures of Kinase Inhibitors and Multitarget Strategies in Alzheimer's Disease Treatment","volume":"32","author":"Tripathi","year":"2025","journal-title":"Protein & Pept. Lett."},{"issue":"8","key":"10.1016\/j.arr.2026.103186_bib134","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","article-title":"Recent advances in the application of metabolomics to Alzheimer\u2019s disease","volume":"1842","author":"Trushina","year":"2014","journal-title":"Biochim. Et. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.arr.2026.103186_bib135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063644","article-title":"Identification of altered metabolic pathways in plasma and CSF","volume":"8","author":"Trushina","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.arr.2026.103186_bib136","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cm.70095","article-title":"Mitochondria and the Actin Cytoskeleton in Neurodegeneration","volume":"83","author":"Tuli","year":"2026","journal-title":"Cytoskeleton (Hoboken)"},{"issue":"15","key":"10.1016\/j.arr.2026.103186_bib137","doi-asserted-by":"crossref","first-page":"7328","DOI":"10.3390\/ijms26157328","article-title":"Are Hippocampal Hypoperfusion and ATP Depletion Prime Movers in the Genesis of Alzheimer\u2019s Disease? A Review of Recent Pertinent Observations from Molecular Biology","volume":"26","author":"Walker","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib138","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13073-016-0355-3","article-title":"Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer\u2019s disease","volume":"8","author":"Wang","year":"2016","journal-title":"Genome Med"},{"issue":"28","key":"10.1016\/j.arr.2026.103186_bib139","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1523\/JNEUROSCI.1357-09.2009","article-title":"Impaired balance of mitochondrial fission and fusion in Alzheimer\u2019s disease","volume":"29","author":"Wang","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"9","key":"10.1016\/j.arr.2026.103186_bib141","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1007\/s10787-025-01916-6","article-title":"Bioenergetic failure and oxidative stress: mitochondrial contributions to Alzheimer\u2019s disease: R. Wasim et al","volume":"33","author":"Wasim","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"2","key":"10.1016\/j.arr.2026.103186_bib142","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","article-title":"Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease","volume":"35","author":"Whiley","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.arr.2026.103186_bib143","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","article-title":"Tau-aggregation inhibitor therapy for Alzheimer\u2019s disease","volume":"88","author":"Wischik","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.arr.2026.103186_bib144","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41531-025-00926-z","article-title":"Disruption of axonal transport in Parkinson\u2019s disease: the role of pathological \u03b1-Syn and AMPK\/p38 MAPK signaling","volume":"11","author":"Yang","year":"2025","journal-title":"npj Park. 's. Dis."},{"issue":"9","key":"10.1016\/j.arr.2026.103186_bib145","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/hmg\/ddw045","article-title":"Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease","volume":"25","author":"Yin","year":"2016","journal-title":"Hum. Mol. Genet"},{"issue":"6098","key":"10.1016\/j.arr.2026.103186_bib146","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.arr.2026.103186_bib147","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic networks in Alzheimer\u2019s disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103186_bib148","doi-asserted-by":"crossref","first-page":"14475","DOI":"10.2147\/JIR.S557000","article-title":"Advances in the understanding of mitochondrial inflammatory regulation in the pathogenesis of Alzheimer\u2019s Disease","author":"Zhang","year":"2025","journal-title":"J. Inflamm. Res."},{"issue":"11","key":"10.1016\/j.arr.2026.103186_bib149","doi-asserted-by":"crossref","first-page":"197","DOI":"10.31083\/j.jin2311197","article-title":"Molecular insights into tau pathology and its therapeutic strategies in Alzheimer's disease","volume":"23","author":"Zhou","year":"2024","journal-title":"J. Integr. Neurosci."},{"issue":"4","key":"10.1016\/j.arr.2026.103186_bib150","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.4103\/NRR.NRR-D-24-01507","article-title":"Inherent potential of mitochondria-targeted interventions for chronic neurodegenerative diseases","volume":"21","author":"Zhou","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2026.103186_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118859","article-title":"Study on the role of Dihuang Yinzi in regulating the AMPK\/SIRT1\/PGC-1\u03b1 pathway to promote mitochondrial biogenesis and improve Alzheimer's disease","volume":"337","author":"Zhu","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.arr.2026.103186_bib152","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/ijms17020246","article-title":"Systems pharmacology in small molecular drug discovery","volume":"17","author":"Zhou","year":"2016","journal-title":"Int. J. Mol. Sci."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163726001789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:44:32Z","timestamp":1780515872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163726001789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":152,"alternative-id":["S1568163726001789"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103186","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting tau-mitochondrial crosstalk in Alzheimer\u2019s disease with an Integrative multi-omics and artificial intelligence driven tools for the development of disease-modifying therapeutics","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103186"}}